Kalshi· Financials

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Pays out if the result is above 8.

Chance

91%

Buy Yes

95¢

pays $1 if it happens

Buy No

13¢

pays $1 if it doesn’t

Prices from Kalshi, updated 11 minutes ago. Ends Mar 31, 5:00 AM UTC.

Price over the last 2 weeks

Cost of a Yes share

If this happens, yours happens tooWill Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?46¢
If this happens, yours happens tooWill Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?60¢
If this happens, yours happens tooWill Medtronic plc report Above 11.5% cardiovascular organic revenue growth in Q2 2027?99¢
If this happens, yours happens tooWill Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?98¢
If this happens, yours happens tooWill Medtronic plc report Above 12% cardiovascular organic revenue growth in Q2 2027?24¢
If this happens, yours happens tooWill Medtronic plc report Above 13% cardiovascular organic revenue growth in Q2 2027?18¢
If this happens, yours happens tooWill Medtronic plc report Above 14% cardiovascular organic revenue growth in Q2 2027?9¢
If this happens, yours happens tooWill Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?80¢

How this market is decidedShow

If Medtronic plc reports Above 8% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.

Related markets